Browsing Tag
SMS Pharmaceuticals Limited
2 posts
SMS Pharmaceuticals FY25 results: PAT up 39%, Rs 250cr capex planned for FY26 growth
SMS Pharmaceuticals posts 39% PAT growth, backed by integration gains and ₹250 Cr expansion. Will margin boosts and product diversification drive FY26 re-rating?
June 1, 2025
Game-changing EDQM certification propels SMS Pharmaceuticals into Europe’s Ibuprofen market
SMS Pharmaceuticals Limited has officially received the coveted EDQM certification, a milestone that positions the Indian-based pharmaceutical giant…
October 1, 2024